AKT1 and pancreatic neoplasm: Additionally, miR-142 plays a role in sensitizing pancreatic cancer cells to doxorubicin by suppressing DJ-1 and subsequently activating PTEN, inactivating the PI3K/AKT signaling pathway, which is often correlated with cancer survival and drug resistance [106].